Siegfried Holding AG operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Siegfried Holding AG with three other
pharmaceutical manufacturers in Europe:
sales of 756.93 million Euro [US$838.24 million]
of which 67%
was Own Network (Spain)),
(669.20 million Euro [US$741.08 million]
of which 100%
was Operating), and
based in France
(789.60 million Euro [US$874.42 million]
of which 44%
Siegfried Holding AG reported sales of 794.30 million Swiss Francs (US$799.90 million)
December of 2018.
increase of 5.8%
versus 2017, when the company's sales were 750.47 million Swiss Francs.
This was the fourth straight year of sales growth at Siegfried Holding AG.
Sales of Drug Products saw an increase
that was more than double the company's growth rate: sales were up
17.1% in 2018, from
169.80 million Swiss Francs to 198.80 million Swiss Francs.